Intellipharmaceutics International Inc. (IPCI) Stock Price & Overview

NASDAQ:IPCI

Current stock price

0.2106
-0.06 (-22%)
At close:
0.2151
+0 (+2.14%)
After Hours:

The current stock price of IPCI is 0.2106 null. Today IPCI is down by -22%. In the past month the price decreased by -44.58%. In the past year, price decreased by -96.49%.

IPCI Key Statistics

52-Week Range0.2 - 6.5
Current IPCI stock price positioned within its 52-week range.
1-Month Range0.21 - 0.4
Current IPCI stock price positioned within its 1-month range.
Market Cap
4.618M
P/E
N/A
Fwd P/E
N/A
EPS (TTM)
-2.89
Dividend Yield
N/A

IPCI Stock Performance

Today
-22%
1 Week
-17.09%
1 Month
-44.58%
3 Months
-24.79%
Longer-term
6 Months -92.93%
1 Year -96.49%
2 Years N/A
3 Years N/A
5 Years N/A
10 Years N/A

IPCI Stock Chart

Intellipharmaceutics International Inc. / IPCI Daily stock chart

IPCI Technical Analysis

ChartMill assigns a technical rating of 0 / 10 to IPCI. When comparing the yearly performance of all stocks, IPCI is a bad performer in the overall market: 99.26% of all stocks are doing better.


Chartmill TA Rating
Chartmill Setup Rating
IPCI Full Technical Analysis Report

IPCI Fundamental Analysis

ChartMill assigns a fundamental rating of 2 / 10 to IPCI. Both the profitability and financial health of IPCI have multiple concerns.


Chartmill FA Analysis
Valuation
Growth
Profitability
Health
Dividend
IPCI Full Fundamental Analysis Report

IPCI Earnings

Next Earnings DateN/A
Last Earnings DateN/A
IPCI Earnings History

IPCI Forecast & Estimates


Analysts
AnalystsN/A
Price TargetN/A
EPS Next Y65.4%
Revenue Next YearN/A
IPCI Forecast & Estimates

IPCI Financial Highlights

Over the last trailing twelve months IPCI reported a non-GAAP Earnings per Share(EPS) of -2.89. The EPS increased by 0.34% compared to the year before.


Income Statements
Revenue(TTM)1.71M
Net Income(TTM)-13.75M
Industry RankSector Rank
PM (TTM) -802.68%
ROA -119.81%
ROE -335.12%
Debt/Equity 0
Chartmill High Growth Momentum
EPS Q2Q%-737.5%
Sales Q2Q%-64.03%
EPS 1Y (TTM)0.34%
Revenue 1Y (TTM)-68.89%
IPCI financials

IPCI Ownership

Ownership
Inst Owners11.05%
Shares21.93M
Float19.98M
Ins OwnersN/A
Short Float %N/A
Short RatioN/A
IPCI Ownership

About IPCI

Company Profile

Intellipharmaceutics International Inc. is engaged in the research, development, and commercialization of controlled-release and targeted pharmaceutical products. Its products include Effexor XR and Protonix. The Company offers products in different stages of development in therapeutic areas, including neurology, cardiovascular, and GIT. Intellipharmaceutics International Inc. was formerly known as IntelliPharmaCeutics Ltd. and is based in Toronto, Canada.

Company Info

Intellipharmaceutics International Inc.

30 WORCESTER ROAD

TORONTO A6 M9W 5X2

CEO: Isa Odidi

Phone: 416-798-3001

Intellipharmaceutics International Inc. / IPCI FAQ

What does IPCI do?

Intellipharmaceutics International Inc. is engaged in the research, development, and commercialization of controlled-release and targeted pharmaceutical products. Its products include Effexor XR and Protonix. The Company offers products in different stages of development in therapeutic areas, including neurology, cardiovascular, and GIT. Intellipharmaceutics International Inc. was formerly known as IntelliPharmaCeutics Ltd. and is based in Toronto, Canada.


What is the stock price of Intellipharmaceutics International Inc. today?

The current stock price of IPCI is 0.2106 null. The price decreased by -22% in the last trading session.


Does Intellipharmaceutics International Inc. pay dividends?

IPCI does not pay a dividend.


How is the ChartMill rating for Intellipharmaceutics International Inc.?

IPCI has a ChartMill Technical rating of 0 out of 10 and a ChartMill Fundamental rating of 2 out of 10.


What is Intellipharmaceutics International Inc. worth?

Intellipharmaceutics International Inc. (IPCI) has a market capitalization of 4.62M null. This makes IPCI a Nano Cap stock.